A Study With L19TNF in Combination With Lomustine in Patients With Glioblastoma at Progression or Recurrence

NCT06336291 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Glioblastoma

Interventions

DRUG: L19TNF
DRUG: L19TNF
DRUG: L19TNF
DRUG: Lomustine
DRUG: Lomustine

Sponsor

Philogen S.p.A.